Day: August 19, 2021

BALTIMORE, Aug. 19, 2021 (GLOBE NEWSWIRE) — Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTCQB: GCAN) a cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has entered into a licensing agreement (the “Agreement”) with Shaare Zedek Scientific Ltd. (“SZS”), the technology transfer arm of Jerusalem’s Shaare Zedek Medical Center (SZMC). The agreement covers the license of SZS’s novel cannabinoid therapeutic focused on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease and other neuropsychiatric disorders. Shaare Zedek Medical Center, founded in 1901, is one of the largest multidisciplinary research hospitals in Israel with 1,000 beds and over 850,000 patient visits a year. The SZMC Center for Research and Development has over 300...

The Abercrombie x The Knot “Best Dressed Guest” collection features curated and co-designed pieces perfectly suited to outfit guests for the busiest wedding and event season everAbercrombie x The Knot Best Dressed Guest CollectionThe Abercrombie x The Knot “Best Dressed Guest” collection features curated and co-designed pieces perfectly suited to outfit guests for the busiest wedding and event season ever.Abercrombie x The Knot Best Dressed Guest CollectionThe Abercrombie x The Knot “Best Dressed Guest” collection features curated and co-designed pieces perfectly suited to outfit guests for the busiest wedding and event season ever.Abercrombie x The Knot Best Dressed Guest CollectionThe Abercrombie x The Knot “Best Dressed Guest” collection features curated and co-designed pieces perfectly...

New York, NY, Aug. 19, 2021 (GLOBE NEWSWIRE) — iQSTEL, Inc. (OTCQB: IQST) today published an Earnings Review and Outlook Update from CEO Leandro Iglesias.  The update follows the release of the Company’s Q2 financial statement for FY-2021 on Form 10Q reporting 88% revenue growth to $30.3 Million in revenue year to date (YTD) compared to $16.1 for the same period FY-2020.  The company has forecasted achieving $60.5 Million in revenue for the full FY-2021. In the Update included its entirety below, Mr. Iglesias highlights key YTD performance achievements and discusses the company’s plans moving forward emphasizing new product developments and operational efficiencies expected to both increase margins and grow sales potentially exceeding the company’s current $60.5 million revenue forecast. CEO Earnings Review and Outlook Update iQSTEL...

Today, The Drilling Company of 1972 A/S (“Maersk Drilling”) provides the following revision of its financial guidance for 2021: Maersk Drilling continues to demonstrate strong operational performance. Particularly, the four deepwater floaters reactivated during Q1 and Q2 2021 have, since contract commencements, continued to outperform original operational expectations in terms of higher financial uptime and lower costs. As a consequence of this performance, Maersk Drilling upgrades its financial guidance for 2021 EBITDA before special items to USD 290-330m (previous guidance of USD 260-310m). The new guidance range reflects ordinary operational uncertainties, including general rig performance, mobilisation for and commencement of new contracts, and uncertainties regarding exercise of options and contract extensions for execution in 2021....

IQE plc Cardiff, UK19 August 2021 Update to the acquisition of minority interests in IQE Taiwan Corporation Result of the Court determination on the valuation of third-party shareholdings in IQE IQE plc (AIM: IQE, “IQE“, “Company” or the “Group“), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, announces the final Court determination of the valuation of the acquisition of third-party shareholdings in IQE Taiwan Corporation (“IQE Taiwan”) as reported by the Company on 15 October 2020 (the “Acquisition”) to take IQE’s ownership from 90.18% to 100%. The Acquisition involved a statutory share swap arrangement under Taiwan’s Business Mergers and Acquisitions Law. Selling shareholders representing circa 5% of the shares in IQE Taiwan,...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES VANCOUVER, British Columbia, Aug. 19, 2021 (GLOBE NEWSWIRE) — Asante Gold Corporation (CSE:ASE/ FRANKFURT:1A9/U.S.OTC:ASGOF) (“Asante” or the “Company”), is pleased to announce the successful completion of the purchase of the Bibiani Gold Mine (Bibiani) in Ghana from Resolute Mining Limited (Resolute) for total cash consideration of US$90 million (see our press release dated 5 August 2021). Resolute has received the initial US$30 million cash payment from Asante with the balance of consideration payable in two equal instalments of US$30 million on or before six and twelve months following closing. Given the successful closing of the purchase, Asante is now finalizing its team that will develop the Bibiani Mine back to production,...

Seattle, WA, Aug. 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — 3DX Industries Inc. (DDDX) (the “Company” or “3DX”), a state of the art additive manufacturer specializing in 3D Metal Printing, announces key hires to their management and operations team.  The team driving the growth and strategy at 3DX Industries, Inc. now includes: Charles Lukey Charles “Luke” Lukey has over 25 years of experience in the manufacturing & project management industry. He began his career at Genie Industries in 1995, where he slashed process inefficiencies resulting in $500K in savings through the conversion of steel deliveries from batch to flow. At National Industrial Concepts he rapidly increased company revenues by $1M by leading the expansion of a value-added assembly line to capitalize on strategy growth opportunities. As a consultant...

CDKL5 Deficiency Disorder (“CDD”) is a severe neurodevelopmental epileptic encephalopathy disorder with no effective treatments or cure Collaboration creates opportunities to identify, validate, and progress new medicines for CDD more rapidly and at a lower cost by derisking biological target and drug candidate selectionCHERRY HILL, NJ and TORONTO, CANADA, Aug. 19, 2021 (GLOBE NEWSWIRE) — Vyant Bio, Inc., (Nasdaq: VYNT), a leading biotech company discovering new therapeutics for neurological diseases and hard-to-treat cancers, and Cyclica, Inc., the partner of choice for data driven drug discovery, today announced a non-exclusive strategic collaboration combining Vyant Bio’s patient-derived complex organoid biology alongside Cyclica’s proteome-wide, Artificial Intelligence (“AI”) enabled discovery platform to identify new treatments...

Anthony JohnsonAnthony Johnson – Board of DirectorsVisionary in the Fields of Biotechnology and Genomics to Extend Broad Expertise to Company’s Strategy, Technology Development, Commercialization, and Value Creation Efforts BUFFALO, N.Y., Aug. 19, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced the appointment of Anthony Johnson to its Board of Directors. Mr. Johnson is an accomplished life sciences and biotechnology executive leader with broad expertise in corporate strategy, technology development, marketing, and business development. Mr. Johnson will serve as a member of the Board’s Scientific Advisory and Compensation Committees. “Anthony...